|
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis 02-04-2012 08:00 Conditions: Diabetes Mellitus; Diabetes Mellitus Complications; GastroparesisInterventions: Drug: RM-131; Drug: PlaceboSponsors: Rhythm Pharmaceuticals, Inc.; Rhythm Pharmaceuticals, Inc.Recruiting - verified May 2012 Read more... |
|
The Healthy Start Project: Primary Prevention of Overweight in Preschool Children Predisposed to Future Overweight 31-03-2012 08:00 Conditions: Overweight; Obesity; PredispositionIntervention: Behavioral: Lifestyle habits, including sleep and stressSponsors: Bispebjerg Hospital; Bispebjerg Hospital; TrygFonden, Denmark; The Danish Medical Research Council; Sygekassernes HelsefondActive, not recruiting - verified April 2012 Read more... |
|
Energy Expenditure Responses to Different Temperatures 30-03-2012 08:00 Conditions: Healthy; ObeseIntervention: Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting - verified March 2012 Read more... |
|
Large Scale Demonstrator, Webportal Diabetes 29-03-2012 08:00 Condition: Diabetes Mellitus Type 2Intervention: Behavioral: Web portalSponsors: Medical Research Foundation, The Netherlands; Nanne Kleefstra; Isala Klinieken; University Medical Centre GroningenRecruiting - verified May 2012 Read more... |
|
Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues 26-03-2012 08:00 Conditions: Diabetes; Diabetes Mellitus, Type 2Interventions: Other: No treatment given; Other: No treatment givenSponsors: Novo Nordisk; Novo NordiskCompleted - verified April 2012 Read more... |
|
Conditions: Impaired Glucose Tolerance; DiabetesIntervention: Drug: exenatideSponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; Amylin Pharmaceuticals, Inc.Recruiting - verified April 2012 Read more... |
|
Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) 19-03-2012 08:00 Conditions: Type 2 Diabetes; Coronary Heart DiseaseIntervention: Drug: pioglitazoneSponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; Takeda Pharmaceuticals North America, Inc.Completed - verified April 2012 Read more... |
|
Study of Offspring of Women With Type 1 Diabetes 19-03-2012 08:00 Condition: Type 1 DiabetesIntervention: Sponsors: Odense University Hospital; Odense University Hospital; University of Copenhagen; Department of Gynaecology and Obstetrics, Rigshospitalet, Copenhagen; Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark; University of Southern Denmark; Diabetes Research Center, Odense University hospital; University of Aarhus; Aarhus University HospitalRecruiting - verified April 2012 Read more... |
|
Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia 15-03-2012 08:00 Condition: HypoglycemiaInterventions: Drug: glucagon; Drug: low dose experimental formulation; Drug: high dose experimental formulation; Drug: Medium dose experimental glucagon formulationSponsors: AMG Medical Inc.; AMG Medical Inc.Recruiting - verified May 2012 Read more... |
|
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers 14-03-2012 08:00 Condition: Diabetic Foot UlcersInterventions: Other: Tissue; Other: ControlSponsors: Osiris Therapeutics; Osiris TherapeuticsRecruiting - verified May 2012 Read more... |
|
A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg 07-03-2012 07:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: Acarbose (Glucobay ODT, BAYG5421); Drug: Acarbose (Glucobay, BAYG5421)Sponsors: Bayer; BayerActive, not recruiting - verified May 2012 Read more... |
|
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 06-03-2012 07:00 Conditions: Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2Intervention: Drug: Bardoxolone MethylSponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.Recruiting - verified May 2012 Read more... |
|
Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients 06-03-2012 07:00 Condition: Diabetic ComplicationsInterventions: Device: Prontosan; Device: SalineSponsors: B. Braun Medical Inc.; B. Braun Medical Inc.Recruiting - verified May 2012 Read more... |
|
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes 06-03-2012 07:00 Condition: Glycemic ControlInterventions: Drug: TAK-875; Drug: Sitagliptin; Drug: PlaceboSponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Centre (Europe) Ltd.Recruiting - verified May 2012 Read more... |
|
Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention) 05-03-2012 07:00 Condition: Thyroiditis, AutoimmuneInterventions: Dietary Supplement: Anatabloc Supplement; Dietary Supplement: PlaceboSponsors: Rock Creek Pharmaceuticals, Inc.; Rock Creek Pharmaceuticals, Inc.Recruiting - verified April 2012 Read more... |
|
Conditions: Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2Intervention: Drug: Bardoxolone MethylSponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.Recruiting - verified May 2012 Read more... |
|
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer 03-03-2012 07:00 Condition: Prostate CancerInterventions: Drug: bicalutamide; Drug: buserelin; Drug: flutamide; Drug: goserelin acetate; Drug: leuprolide acetate; Drug: orteronel; Drug: triptorelinSponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)Not yet recruiting - verified May 2012 Read more... |
|
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases 02-03-2012 07:00 Conditions: Retinal Dystrophies; Age-related Macular Degeneration; Arterial Hypertension; Diabetes; Traumatic Retinopathy; Toxic RetinopathiesIntervention: Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, FranceRecruiting - verified March 2012 Read more... |
|
Metformin Add-on Regimen Comparison Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-0431A-136) 01-03-2012 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Sitagliptin; Drug: Metformin; Drug: Metformin; Drug: PlaceboSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021) 28-02-2012 07:00 Condition: Diabetic Neuropathy, PainfulInterventions: Drug: MK-6096; Drug: PlaceboSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
Weight Loss With Exenatide Treatment 24-02-2012 07:00 Condition: ObesityInterventions: Drug: Exenatide; Drug: Placebo; Behavioral: Dietary counselingSponsors: Beth Israel Deaconess Medical Center; Eleftheria Maratos-Flier; Amylin Pharmaceuticals, Inc.Recruiting - verified May 2012 Read more... |
|
Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes 23-02-2012 07:00 Condition: Type 1 Diabetes MellitusInterventions: Drug: Technosphere Insulin Inhalation Powder; Drug: Rapid Acting AnalogSponsors: Mannkind Corporation; Mannkind CorporationRecruiting - verified May 2012 Read more... |
|
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts 23-02-2012 07:00 Condition: Hypercholesterolemia With Concomitant Type 2 DiabetesInterventions: Drug: Atorvastatin; Drug: RosuvastatinSponsors: Listen Trial Group; Listen Trial GroupRecruiting - verified April 2012 Read more... |
|
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes 23-02-2012 07:00 Conditions: Diabetes; Diabetes Mellitus, Type 2Interventions: Drug: liraglutide; Drug: placebo; Drug: metforminSponsors: Novo Nordisk; Novo NordiskNot yet recruiting - verified April 2012 Read more... |
|
Diabetic Foot Infection Antibiotic Study 22-02-2012 07:00 Condition: Diabetic Foot InfectionsInterventions: Procedure: Surgical incision and drainage of diabetic foot infection; Drug: Short course antibiotics; Drug: Long course antibioticsSponsors: Greenville Hospital System University Medical Center; Greenville Hospital System University Medical CenterTerminated - verified May 2012 Read more... |
|
Condition: Prostate CancerIntervention: Sponsors: University of Waterloo; University of Waterloo; Grand River Regional Cancer CentreRecruiting - verified May 2012 Read more... |
|
Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers 17-02-2012 07:00 Condition: Diabetes MellitusInterventions: Drug: Matching placebo; Drug: PBL 1427 capsulesSponsors: Panacea Biotec Ltd; Panacea Biotec LtdNot yet recruiting - verified May 2012 Read more... |
|
A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers 17-02-2012 07:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: PF-05175157; Drug: PF-05175157; Drug: PF-05175157; Drug: PlaceboSponsors: Pfizer; PfizerRecruiting - verified April 2012 Read more... |
|
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes 16-02-2012 07:00 Conditions: Diabetes; Diabetes Mellitus, Type 1Interventions: Drug: liraglutide; Drug: placeboSponsors: Novo Nordisk; Novo NordiskActive, not recruiting - verified May 2012 Read more... |
|
Predicting Response to Standardized Pediatric Colitis Therapy 16-02-2012 07:00 Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: Prednisone; Drug: Corticosteroids followed by mesalamine (Pentasa)Sponsors: Connecticut Children's Medical Center; Connecticut Children's Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting - verified April 2012 Read more... |
|
Clinical Trial of Safety and Efficiency of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients 14-02-2012 07:00 Condition: ObesityInterventions: Drug: Dietressa; Device: PlaceboSponsors: Materia Medica Holding; Materia Medica HoldingRecruiting - verified May 2012 Read more... |
|
Condition: Type 1 DiabetesInterventions: Drug: Pro insulin peptide; Drug: Pro insulin peptide; Drug: SalineSponsors: Cardiff University; Cardiff University; Diabetes Vaccine Development Centre; Juvenile Diabetes Research FoundationRecruiting - verified April 2012 Read more... |
|
Global SYMPLICITY Registry 13-02-2012 07:00 Conditions: Hypertension; Diabetes Mellitus; Heart Failure; Chronic Kidney Disease; Sleep ApneaIntervention: Device: Medtronic Renal Denervation SystemSponsors: Medtronic Vascular; Medtronic VascularRecruiting - verified April 2012 Read more... |
|
Conditions: Diabetic Peripheral Neuropathy; PainInterventions: Drug: QUTENZA; Drug: PlaceboSponsors: Astellas Pharma Inc; Astellas Pharma IncRecruiting - verified May 2012 Read more... |
|
Non Invasive Breath Based Glucometer- Easy Check 07-02-2012 07:00 Condition: Type 1 DiabetesIntervention: Device: Easy CheckSponsors: Rabin Medical Center; Rabin Medical CenterRecruiting - verified April 2012 Read more... |
|
PK Study of Dapagliflozin in Pediatric Subjects With T2DM 31-01-2012 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: DapagliflozinSponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca; ParexelNot yet recruiting - verified April 2012 Read more... |
|
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM 31-01-2012 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Metformin IR; Drug: Saxagliptin; Drug: Metformin IR; Drug: Saxagliptin/Metformin XR FDC; Drug: Metformin XRSponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZenecaNot yet recruiting - verified April 2012 Read more... |
|
A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe 31-01-2012 07:00 Condition: Diabetes Mellitus, Type 2Intervention: Biological: DulaglutideSponsors: Eli Lilly and Company; Eli Lilly and CompanyActive, not recruiting - verified May 2012 Read more... |
|
Study of Combination Therapy With SYR-322 26-01-2012 07:00 Condition: Diabetes MellitusInterventions: Drug: Alogliptin; Drug: InsulinSponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company LimitedRecruiting - verified May 2012 Read more... |
|
Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy 25-01-2012 07:00 Condition: Type 2 DiabetesInterventions: Drug: Transient Continuous Subcutaneous Insulin Infusion; Drug: Transient Multiple Daily Insulin InjectionsSponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of MedicineRecruiting - verified April 2012 Read more... |
|
Pioglitazone to Treat Opioid Withdrawal Symptoms 24-01-2012 07:00 Condition: Opioid-Related DisordersInterventions: Drug: Pioglitazone; Drug: PlaceboSponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)Recruiting - verified November 2011 Read more... |
|
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin 24-01-2012 07:00 Conditions: Diabetes; Diabetes Mellitus, Type 2Interventions: Drug: biphasic insulin aspart 30; Drug: biphasic insulin aspart 30; Drug: sitagliptin; Drug: metforminSponsors: Novo Nordisk; Novo NordiskNot yet recruiting - verified May 2012 Read more... |
|
Condition: Nonalcoholic Fatty Liver Disease (NAFLD)Interventions: Drug: delayed release cysteamine bitartrate; Other: DR cysteamine bitartrate placeboSponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting - verified April 2012 Read more... |
|
Japanese Phase 1 Multiple Ascending Dose Study 18-01-2012 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: BMS-823778; Drug: BMS-823778; Drug: BMS-823778; Drug: BMS-823778; Drug: Placebo matching with BMS-823778Sponsors: Bristol-Myers Squibb; Bristol-Myers SquibbRecruiting - verified May 2012 Read more... |
|
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin 16-01-2012 07:00 Condition: Type 2 Diabetes MellitusIntervention: Drug: Lixisenatide (AVE0010)Sponsors: Sanofi-Aventis; Sanofi-AventisRecruiting - verified May 2012 Read more... |
|
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes 16-01-2012 07:00 Conditions: Diabetes; Diabetes Mellitus, Type 2Interventions: Drug: insulin degludec/insulin aspart; Drug: biphasic insulin aspart 30Sponsors: Novo Nordisk; Novo NordiskActive, not recruiting - verified May 2012 Read more... |
|
A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus 16-01-2012 07:00 Conditions: Diabetes; Diabetes Mellitus, Type 1Interventions: Drug: insulin degludec; Drug: insulin detemir; Drug: insulin aspartSponsors: Novo Nordisk; Novo NordiskRecruiting - verified May 2012 Read more... |
|
Linaglitpin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes 16-01-2012 07:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: metformin; Drug: linagliptin; Drug: linagliptin medium dose; Drug: metformin placebo; Drug: metformin placeboSponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and CompanyRecruiting - verified May 2012 Read more... |
|
To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately 13-01-2012 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Dapagliflozin + Glucophage tablet fasted; Drug: Dapagliflozin/metformin IR FDC tablet fasted; Drug: Dapagliflozin + Glucophage tablet fed; Drug: Dapagliflozin/metformin IR FDC tablet fedSponsors: AstraZeneca; AstraZeneca; Bristol-Myers SquibbWithdrawn - verified April 2012 Read more... |
|
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone 10-01-2012 07:00 Conditions: Diabetes; Diabetes Mellitus, Type 2Intervention: Drug: liraglutideSponsors: Novo Nordisk; Novo NordiskActive, not recruiting - verified May 2012 Read more... |
|
Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialysis Patients 06-01-2012 07:00 Condition: Stage 5 Chronic Kidney DiseaseIntervention: Other: Multidisciplinary, intensive and collaborative careSponsors: National University, Singapore; National University, SingaporeRecruiting - verified April 2012 Read more... |
|
Vitamin D3 Supplementation Pilot Study 04-01-2012 07:00 Condition: Vitamin D DeficiencyInterventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: CholecalciferolSponsors: Children's Hospital of Philadelphia; Children's Hospital of PhiladelphiaRecruiting - verified May 2012 Read more... |
|
Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients on Oral Antidiabetic Medication 03-01-2012 07:00 Conditions: Type 2 Diabetes Mellitus (Non-insulin-dependent); Iron Deficiency AnemiaInterventions: Drug: ferric carboxymaltose; Drug: NaCl (0,9%)Sponsors: GWT-TUD GmbH; GWT-TUD GmbH; Vifor PharmaNot yet recruiting - verified May 2012 Read more... |
|
MDRS for Prevention of Nocturnal Hypoglycemia 25-12-2011 07:00 Condition: Type 1 DiabetesInterventions: Device: MDRS System (Remote & Safety diabetes management system); Procedure: Continuous Glucose MonitoringSponsors: Rabin Medical Center; Rabin Medical CenterRecruiting - verified April 2012 Read more... |
|
Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2) 22-12-2011 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Vildagliptin; Drug: PlaceboSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
Family Genetics Health Education and Healthy Behaviors 21-12-2011 07:00 Conditions: Diabetes; Cancer; Heart DiseaseIntervention: Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)Recruiting - verified October 2011 Read more... |
|
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes 21-12-2011 07:00 Condition: Type 1 Diabetes MellitusInterventions: Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Placebo matching DapagliflozinSponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZenecaRecruiting - verified February 2012 Read more... |
|
NEI Intramural Biorepository for Retinal Diseases 17-12-2011 07:00 Conditions: Age-Related Macular Degeneration; Diabetic Retinopathy; Von Hippel-Lindau Syndrome; Retinal Disease; Retinal Vein OcclusionIntervention: Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)Recruiting - verified May 2012 Read more... |
|
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin 16-12-2011 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: HOE 901 - New formulation of insulin glargine; Drug: HOE 901 - Insulin glargineSponsors: Sanofi-Aventis; Sanofi-AventisRecruiting - verified May 2012 Read more... |
|
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy 16-12-2011 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: HOE 901 - Insulin glargine; Drug: HOE901 - Insulin glargine-new formulationSponsors: Sanofi-Aventis; Sanofi-AventisRecruiting - verified May 2012 Read more... |
|
Conditions: Diabetes; Diabetes Mellitus, Type 2Interventions: Drug: insulin detemir; Drug: insulin aspart; Drug: insulin NPH; Drug: human soluble insulin; Drug: metforminSponsors: Novo Nordisk; Novo NordiskRecruiting - verified May 2012 Read more... |
|
Peripheral Nerve Stimulation in Diabetic Patients 02-12-2011 07:00 Condition: Diabetic PolyneuropathyIntervention: Procedure: peripheral nerve stimulationSponsors: Medical University of Graz; Medical University of GrazRecruiting - verified April 2012 Read more... |
|
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083) 01-12-2011 07:00 Conditions: Diabetes Mellitus; Type 2 DiabetesInterventions: Drug: Sitagliptin; Drug: Metformin; Drug: Placebo to sitagliptin; Drug: Placebo to metforminSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) 30-11-2011 07:00 Condition: Critical Limb IschemiaInterventions: Biological: Ixmyelocel-T; Other: Vehicle ControlSponsors: Aastrom Biosciences; Aastrom BiosciencesRecruiting - verified May 2012 Read more... |
|
A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus 30-11-2011 07:00 Conditions: Diabetes Mellitus, Type 2; Plasma VolumeInterventions: Drug: Canagliflozin; Drug: PlaceboSponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLCRecruiting - verified April 2012 Read more... |
|
Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus 29-11-2011 07:00 Condition: Type 1 Diabetes MellitusInterventions: Drug: Insulin glargine HOE901; Drug: Insulin glargine - New formulation HOE901Sponsors: Sanofi-Aventis; Sanofi-AventisCompleted - verified April 2012 Read more... |
|
L-Arginine, Vascular Response and Mechanisms 28-11-2011 07:00 Conditions: Hypertension; DiabetesInterventions: Dietary Supplement: L-Arginine; Dietary Supplement: Placebo SupplementSponsors: Brigham and Women's Hospital; Brigham and Women's HospitalRecruiting - verified April 2012 Read more... |
|
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes 25-11-2011 07:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: TAK-875; Drug: TAK-875; Drug: GlimepirideSponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.Recruiting - verified May 2012 Read more... |
|
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) 19-11-2011 07:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Sitagliptin; Drug: Atorvastatin; Other: Placebo to sitagliptin; Other: Placebo to atorvastatin; Drug: Metformin; Drug: Glimepiride; Drug: Placebo to glimepirideSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) 15-11-2011 07:00 Condition: Diabetic Peripheral NeuropathyInterventions: Drug: Pregabalin; Other: placeboSponsors: Pfizer; PfizerRecruiting - verified May 2012 Read more... |
|
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170) 11-11-2011 07:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: Metformin; Drug: Sitagliptin / Metformin; Drug: Placebo to Metformin; Drug: Placebo to Sitagliptin / MetforminSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
A Study in Participants With Type 2 Diabetes Mellitus 08-11-2011 07:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: LY2605541; Drug: Insulin Glargine; Drug: Insulin LisproSponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim PharmaceuticalsRecruiting - verified April 2012 Read more... |
|
Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients 04-11-2011 08:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Insulin glargine /lixisenatide fixed combination (HOE901/AVE0010); Drug: Insulin glargine (HOE901)Sponsors: Sanofi-Aventis; Sanofi-AventisRecruiting - verified May 2012 Read more... |
|
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care 04-11-2011 08:00 Conditions: Colorectal Cancer; Breast Cancer; Coronary Heart Disease; DiabetesIntervention: Other: risk assessment survey; decision support for providers for prevention based on riskSponsors: Brigham and Women's Hospital; Brigham and Women's HospitalNot yet recruiting - verified May 2012 Read more... |
|
Glutamine and Insulin Sensitivity in Type I Diabetes 02-11-2011 08:00 Condition: Type I Diabetes MellitusInterventions: Dietary Supplement: Glutamine; Dietary Supplement: PlaceboSponsors: Nemours Children's Clinic; Nemours Children's Clinic; Thrasher Research FundRecruiting - verified May 2012 Read more... |
|
Vitamin D and Adipose Tissue Inflammation 01-11-2011 08:00 Conditions: Vitamin D Deficiency; Obesity; Type 2 Diabetes MellitusIntervention: Dietary Supplement: Vitamin D3Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; University of WashingtonRecruiting - verified May 2012 Read more... |
|
GLORIA-AF Registry Program - Second and Third Phases 28-10-2011 08:00 Conditions: Stroke; Atrial FibrillationIntervention: Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim PharmaceuticalsRecruiting - verified May 2012 Read more... |
|
Condition: Chronic GoutIntervention: Biological: pegloticaseSponsors: Savient Pharmaceuticals; Savient PharmaceuticalsRecruiting - verified May 2012 Read more... |
|
Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260 AM2) 27-10-2011 08:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Sitagliptin; Drug: Comparator: Placebo; Biological: Insulin Glargine; Drug: MetforminSponsors: Merck; MerckRecruiting - verified May 2012 Read more... |
|
Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients 24-10-2011 08:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: GLIMEPIRIDE; Drug: METFORMINSponsors: Sanofi-Aventis; Sanofi-AventisRecruiting - verified May 2012 Read more... |
|
Graz Study on the Risk of Atrial Fibrillation 23-10-2011 08:00 Conditions: Atrial Fibrillation; Hypertension; Diabetes; Chronic Heart Failure; Vascular DiseaseIntervention: Device: Medtronic Reveal XT implantable loop recorderSponsors: Medical University of Graz; Medical University of Graz; MedtronicRecruiting - verified May 2012 Read more... |
|
Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin 20-10-2011 08:00 Condition: Type 2 Diabetes MellitusInterventions: Drug: Glimepiride and Metformin hydrochloride combination (HOE490); Drug: Glimepiride (HOE490)Sponsors: Sanofi-Aventis; Sanofi-AventisRecruiting - verified May 2012 Read more... |
|
A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Subjects 19-10-2011 08:00 Condition: Diabetes Mellitus, Type 2Interventions: Drug: Ortho-Cyclen; Biological: DulaglutideSponsors: Eli Lilly and Company; Eli Lilly and CompanyCompleted - verified May 2012 Read more... |
|
Condition: Diabetes Mellitus, Type 2Interventions: Drug: Placebo; Drug: TAK-875; Drug: TAK-875Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.Recruiting - verified May 2012 Read more... |
|
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes 18-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: ITCA 650 60 mcg/day; Drug: sitagliptinSponsors: Intarcia Therapeutics; Intarcia TherapeuticsNot yet recruiting - verified May 2012 Read more... |
|
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes 18-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: ITCA 650; Drug: glimepirideSponsors: Intarcia Therapeutics; Intarcia TherapeuticsNot yet recruiting - verified April 2012 Read more... |
|
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes 18-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: ITCA 650 60 mcg/day; Drug: sitagliptinSponsors: Intarcia Therapeutics; Intarcia TherapeuticsNot yet recruiting - verified April 2012 Read more... |
|
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 18-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: ITCA 650; Other: ITCA placeboSponsors: Intarcia Therapeutics; Intarcia TherapeuticsNot yet recruiting - verified April 2012 Read more... |
|
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes 18-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: ITCA 650 60 mcg/day; Drug: glimepirideSponsors: Intarcia Therapeutics; Intarcia TherapeuticsNot yet recruiting - verified April 2012 Read more... |
|
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes 18-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: ITCA 650; Other: ITCA placeboSponsors: Intarcia Therapeutics; Intarcia TherapeuticsNot yet recruiting - verified April 2012 Read more... |
|
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain 17-10-2011 08:00 Condition: Painful Diabetic Peripheral NeuropathyInterventions: Drug: pregabalin; Drug: placeboSponsors: Pfizer; PfizerRecruiting - verified May 2012 Read more... |
|
AMG 151 Amgen Protocol Number 20100761 14-10-2011 08:00 Condition: Diabetes MellitusIntervention: Drug: AMG 151Sponsors: Amgen; AmgenRecruiting - verified April 2012 Read more... |
|
Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice 13-10-2011 08:00 Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Delivery SystemsInterventions: Device: FlexPen®; Device: NovoPen® 3Sponsors: Novo Nordisk; Novo NordiskActive, not recruiting - verified April 2012 Read more... |
|
Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis 12-10-2011 08:00 Conditions: Gastroparesis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2Interventions: Drug: Placebo; Drug: 10mg TZP-102; Drug: 20mg TZP-102Sponsors: Tranzyme, Inc.; Tranzyme, Inc.Recruiting - verified April 2012 Read more... |
|
Conditions: Dyslipidaemia; Insulin ResistanceIntervention: Drug: ResveratrolSponsors: University Health Network, Toronto; University Health Network, Toronto; Canadian Institutes of Health Research (CIHR)Active, not recruiting - verified May 2012 Read more... |
|
Conditions: Metabolic Disease; Diabetes MellitusInterventions: Other: No drug; Other: No drugSponsors: Bayer; BayerNot yet recruiting - verified May 2012 Read more... |
|
Comparison of Technosphere Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus 07-10-2011 08:00 Condition: Type 2 DiabetesInterventions: Drug: Technosphere Insulin; Drug: Technosphere Inhalation PowderSponsors: Mannkind Corporation; Mannkind CorporationRecruiting - verified May 2012 Read more... |
|
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy 04-10-2011 08:00 Conditions: Diabetic Nephropathy; Type 2 Diabetes MellitusInterventions: Drug: Placebo; Drug: CCX140-B; Drug: CCX140-BSponsors: ChemoCentryx; ChemoCentryxRecruiting - verified May 2012 Read more... |
|
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) 30-09-2011 08:00 Conditions: Choroidal Neovascularization; Diabetic Retinopathy; Diabetic Macular EdemaInterventions: Drug: PF-04523655 (Stratum I); Drug: PF-04523655 and ranibizumab; Drug: ranibizumab; Drug: PF-04523655 (Stratum II)Sponsors: Quark Pharmaceuticals; Quark PharmaceuticalsRecruiting - verified April 2012 Read more... |
|
Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period 30-09-2011 08:00 Condition: Type 1 Diabetes MellitusInterventions: Drug: Technosphere Insulin with MedToneC Inhaler in combination with a basal insulin; Drug: Technosphere Insulin with Gen2C Inhaler in combination with a basal insulin; Drug: Insulin Aspart in combination with a basal insulinSponsors: Mannkind Corporation; Mannkind CorporationRecruiting - verified May 2012 Read more... |
Ask the Experts 
Presentations 
Downloads 
Teaching Materials 